Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019
Parnell Pharmaceuticals Holdings Ltd. announced financial results for the full year ended 31 December 2018. For the year, the company reported revenue growth of 39% over the full year in 2017 to $26.5 million and Net Profit After Tax of $0.1 million, an improvement of $23.3 million over a full year loss of $23.1 million in 2017.
For the year 2019, the company's expects full year revenue guidance to be of $31.0 to $33.0 million. This guidance represents a 17% to 25% increase in revenues.